Annual report pursuant to Section 13 and 15(d)

Patents and Other Intangible Assets

v3.8.0.1
Patents and Other Intangible Assets
12 Months Ended
Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]  
Patents and Other Intangible Assets
Patents and Other Intangible Assets

Patents and other intangible assets consist of the following at December 31, 2017 and 2016:
 
 
 
 
 
 
Weighted-Average
 
 
 
 
 
 
Remaining
 
 
(in thousands)
 
(in thousands)
 
Amortization
 
 
2017
 
2016
 
Period
Patents
 
$
1,769

 
$
1,643

 
5 years
Software
 
446

 
446

 
1 year
Customer list - vivoPharm acquisition
 
2,738

 

 
10 years
Trade name - vivoPharm acquisition
 
477

 

 
10 years
 
 
5,430

 
2,089

 
 
Less accumulated amortization
 
(952
)
 
(586
)
 
 
Net patent and other intangible assets
 
$
4,478

 
$
1,503

 
 

The customer list and trade name in the table above include foreign currency translation gains of approximately $38,000 and $17,000, respectively, at December 31, 2017.
Future amortization expense for legally approved patents (excluding patent applications in progress of approximately $570,000 as of December 31, 2017) and other intangible assets, is estimated as follows (in thousands):
2018
$
522

2019
472

2020
461

2021
458

2022
439

2023 and thereafter
1,556

Total
$
3,908